2017
DOI: 10.1007/s12687-017-0302-z
|View full text |Cite
|
Sign up to set email alerts
|

Engaging a state: Facebook comments on a large population biobank

Abstract: Scholarship on newborn screening, dried bloodspot retention, and large population biobanking call consistently for improved public engagement. Communication with participants likely occurs only in the context of collection, consent, or notification, if at all. We ran an 11-week advertising campaign to inform Michigan Facebook users unlikely to know that their or their children's dried bloodspots (DBSs) were stored in a state biobank. We investigated the pattern and content of comments posted during the campaig… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 58 publications
0
9
0
Order By: Relevance
“…Perhaps for this reason, somatic therapies are seen as more acceptable than germline therapies 8 , 47 . Costs are also a cause for concern 34 , 35 , particularly if high costs lead to inequalities in access to genetic modification therapies 48 . This is a concern particularly in the US context due to a lack of universal health coverage 35 .…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Perhaps for this reason, somatic therapies are seen as more acceptable than germline therapies 8 , 47 . Costs are also a cause for concern 34 , 35 , particularly if high costs lead to inequalities in access to genetic modification therapies 48 . This is a concern particularly in the US context due to a lack of universal health coverage 35 .…”
Section: Resultsmentioning
confidence: 99%
“…People in England are generally willing to have genetic data shared in a healthcare context and for this to be used for research activities 44 , but not to the same extent as for the application of genetic and genomic technologies to deliver clinical care 17 . Negative attitudes towards genomics generally stem from concerns around data use, confidentiality, and privacy 17 , 34 36 , 44 , 48 , 49 , 51 , and incidents in which the NHS failed to securely store data may play into fears around mishandling of data 44 . Indeed, members of the public with more personal experience of genetics in relation to health and disease in their family 17 , 35 , 38 40 , 49 have more positive attitudes toward genetics and genomics but also have more concerns about how genetic data are used.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…(1) protecting children and advancing the science of pediatric disease (Bertier et al 2017;Manhas et al 2016;McGuire, Oliver, et al 2011;Burstein et al 2014;Nature Biotechnology 2015;Hens, L evesque, et al 2011;Platt et al 2017;Fisher, McCarthy, and Harrington 2013;Hens, Wright, and Dierickx 2009;Dowty and Korff 2009;Manolio et al 2007); (2) respecting individual rights versus serving public interests (Ahrens et al 2006;Petrini et al 2012); and (3) preserving data privacy versus activating a right to data access (Golding 2009;Nooner et al 2012). The majority of records implied that balancing benefits with informational risks (17 reason mentions) is complicated, given the uncertainties of data privacy/and security at the time of data contribution (Dowty and Korff 2009;Bertier et al 2017;Manhas et al 2016 i.…”
Section: Benefits and Risksmentioning
confidence: 99%